Yokohama, Japan

Shun-Ichi Hata


Average Co-Inventor Count = 9.9

ph-index = 4

Forward Citations = 73(Granted Patents)


Company Filing History:


Years Active: 1981-1984

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Shun-Ichi Hata: Innovator in Pharmaceutical Chemistry

Introduction

Shun-Ichi Hata is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on various chemical compounds. With a total of 7 patents to his name, Hata's inventions focus on developing new medicinal compounds that address critical health issues.

Latest Patents

Hata's latest patents include a dibenzoxazepine derivative and a pharmaceutical composition comprising these derivatives. The compounds he has developed exhibit lipid-lowering activity, blood sugar-lowering activity, and the ability to inhibit platelet aggregation. These properties make them valuable in treating diseases related to circulatory organs. Additionally, he has worked on pyrazoloindazole derivatives, which have bronchodilating action and are also useful as medicines.

Career Highlights

Shun-Ichi Hata is associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. His work at Chugai has allowed him to focus on innovative drug development, contributing to advancements in medical treatments.

Collaborations

Hata has collaborated with notable colleagues, including Yasushi Murakami and Tamotsu Yamazaki. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.

Conclusion

Shun-Ichi Hata's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for innovative medical solutions that address significant health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…